• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Kaposi's Sarcoma of the Eyelid in a Patient With AIDS

Article

A painful swelling over the right lower eyelid with conjunctival injection was evaluated in a 28-year-old injection drug user. Cephalexin and corticosteroid ophthalmic drops failed to resolve the condition.

A painful swelling over the right lower eyelid with conjunctival injection was evaluated in a 28-year-old injection drug user. Cephalexin and corticosteroid ophthalmic drops failed to resolve the condition.

Dr Navin M. Amin of the Kern Medical Center in Bakersfield, Calif, writes that the patient reported weight loss and complained of increasing fatigue, fever with profuse night sweats, and watery diarrhea. In addition to the purplish lesion over the right eye, the clinical examination revealed a lean, wasted man with a temperature of 38.1°C (100.6°F). Oral candidiasis with generalized lymphadenopathy was detected.

The white blood cell count was 2,800/mL; hemoglobin, 11 g/dL; platelet count, 182,000/mL; total CD4 count, 96/mL; and HIV load, 684,720 copies/mL. A biopsy of the eyelid lesion confirmed a diagnosis of Kaposi's sarcoma.

The patient was given zidovudine, lamivudine, and nelfinavir, in addition to prophylactic trimethoprim-sulfamethoxazole. The eyelid lesion receded in 3 months.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
"Obesity is a Medically Approachable Problem" and Other Lessons with Lee Kaplan, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.